Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables: 2020-2025

Historic Receivables for Cellebrite DI (CLBT) over the last 3 years, with Sep 2025 value amounting to $104.2 million.

  • Cellebrite DI's Receivables rose 11.17% to $104.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $443.4 million, marking a year-over-year increase of 6.53%. This contributed to the annual value of $163.7 million for FY2024, which is 1.65% down from last year.
  • Per Cellebrite DI's latest filing, its Receivables stood at $104.2 million for Q3 2025, which was up 11.89% from $93.1 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Receivables high stood at $166.4 million for Q4 2023, and its period low was $77.3 million during Q2 2024.
  • Over the past 3 years, Cellebrite DI's median Receivables value was $93.1 million (recorded in 2025), while the average stood at $104.3 million.
  • Per our database at Business Quant, Cellebrite DI's Receivables soared by 39.45% in 2021 and then decreased by 1.89% in 2024.
  • Over the past 5 years, Cellebrite DI's Receivables (Quarterly) stood at $139.8 million in 2021, then increased by 14.69% to $160.3 million in 2022, then grew by 3.84% to $166.4 million in 2023, then dropped by 1.65% to $163.7 million in 2024, then grew by 11.17% to $104.2 million in 2025.
  • Its Receivables stands at $104.2 million for Q3 2025, versus $93.1 million for Q2 2025 and $82.4 million for Q1 2025.